Cargando…

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life

OBJECTIVE: To examine how clinical and demographic patient baseline characteristics influence effectiveness of duloxetine versus selective serotonin reuptake inhibitor (SSRI) treatment, in real-world Japanese clinical settings of patients with major depressive disorder (MDD) and associated painful p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuga, Atsushi, Tsuji, Toshinaga, Hayashi, Shinji, Fujikoshi, Shinji, Tokuoka, Hirofumi, Yoshikawa, Aki, Escobar, Rodrigo, Tanaka, Kazuhide, Azekawa, Takaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552140/ https://www.ncbi.nlm.nih.gov/pubmed/28831260 http://dx.doi.org/10.2147/NDT.S136448

Ejemplares similares

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
por: Kuga, Atsushi, et al.
Publicado: (2017)

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
por: Kuga, Atsushi, et al.
Publicado: (2019)

Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine
por: Tokuoka, Hirofumi, et al.
Publicado: (2017)

Relationship Between Pain Alleviation and Disease-specific Health-related Quality of Life Measures in Patients With Chronic Low Back Pain Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study
por: Enomoto, Hiroyuki, et al.
Publicado: (2019)

Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials
por: Harada, Eiji, et al.
Publicado: (2015)

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
por: Alev, Levent, et al.
Publicado: (2017)

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin
por: Enomoto, Hiroyuki, et al.
Publicado: (2018)

Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study
por: Enomoto, Hiroyuki, et al.
Publicado: (2020)

Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials
por: Harada, E, et al.
Publicado: (2015)

Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies
por: Enomoto, Hiroyuki, et al.
Publicado: (2017)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
por: Haider, Miqdad, et al.
Publicado: (2017)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada, Eiji, et al.
Publicado: (2015)

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
por: Ogawa, Kei, et al.
Publicado: (2015)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
por: Sugawara, Norio, et al.
Publicado: (2020)

Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study
por: Takahashi, Michihiro, et al.
Publicado: (2015)

Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study
por: Tsuji, Toshinaga, et al.
Publicado: (2017)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study
por: Itoh, Naohiro, et al.
Publicado: (2018)

Factors associated with diabetic polyneuropathy‐related sensory symptoms and signs in patients with polyneuropathy: A cross‐sectional Japanese study (JDDM 52) using a non‐linear model
por: Yokoyama, Hiroki, et al.
Publicado: (2019)

Placental glucocorticoid receptors are not affected by maternal depression or SSRI treatment
por: Edvinsson, Åsa, et al.
Publicado: (2020)

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups
por: Bradley, Laurence A, et al.
Publicado: (2010)

Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study
por: Uchio, Yuji, et al.
Publicado: (2018)

Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study
por: Harada, Eiji, et al.
Publicado: (2017)

Depression Treatment with Duloxetine and Reduction of Inability to Work
por: Happich, Michael, et al.
Publicado: (2012)

The incremental burden of pain in patients with depression: results of a Japanese survey
por: Vietri, Jeffrey, et al.
Publicado: (2015)

A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
por: Uchio, Yuji, et al.
Publicado: (2018)

Combining an SSRI with an anticonvulsant in depressed patients with dysphoric mood: an open study
por: Pasquini, Massimo, et al.
Publicado: (2007)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients
por: Godlewska, B. R., et al.
Publicado: (2012)

Follow-Up of New SSRI Prescriptions for Depression and Anxiety in Primary Care
por: Hughes, Stephen
Publicado: (2022)

Attributes of response in depressed patients switched to treatment with duloxetine
por: Sagman, D, et al.
Publicado: (2011)

Serotonin Syndrome From Duloxetine Monotherapy: A Case Report
por: Li, Liumin, et al.
Publicado: (2023)

Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
por: Cheon, Eun-Jin, et al.
Publicado: (2016)

A systematic review of Chinese randomized clinical trials of SSRI treatment of depression
por: Zhang, Ying, et al.
Publicado: (2014)

Clinical characteristics associated with the prescribing of SSRI medication in adolescents with major unipolar depression
por: Cousins, Lesley, et al.
Publicado: (2016)

SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli
por: Preuss, Antonia, et al.
Publicado: (2020)

Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
por: Pasi, Patrick, et al.
Publicado: (2023)

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
por: Goodwin, Guy M., et al.
Publicado: (2023)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada, Eiji, et al.
Publicado: (2016)

The added burden of depression in patients with osteoarthritis in Japan
por: Tsuji, Toshinaga, et al.
Publicado: (2019)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_gud9ujrounk2e71u1akesophf2